122 related articles for article (PubMed ID: 25885427)
1. Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia.
Eriksson A; Österroos A; Hassan S; Gullbo J; Rickardson L; Jarvius M; Nygren P; Fryknäs M; Höglund M; Larsson R
Blood Cancer J; 2015 Apr; 5(4):e307. PubMed ID: 25885427
[TBL] [Abstract][Full Text] [Related]
2. Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.
Eriksson A; Chantzi E; Fryknäs M; Gullbo J; Nygren P; Gustafsson M; Höglund M; Larsson R
Leuk Res; 2017 Dec; 63():41-46. PubMed ID: 29100024
[TBL] [Abstract][Full Text] [Related]
3. Cooperative antiproliferative and differentiation-enhancing activity of medicinal plant extracts in acute myeloid leukemia cells.
Zhamanbayeva GT; Aralbayeva AN; Murzakhmetova MK; Tuleukhanov ST; Danilenko M
Biomed Pharmacother; 2016 Aug; 82():80-9. PubMed ID: 27470342
[TBL] [Abstract][Full Text] [Related]
4. SAR-guided development and characterization of a potent antitumor compound toward B-cell neoplasms with no detectable cytotoxicity toward healthy cells.
Brunhofer-Bolzer G; Le T; Dyckmanns N; Knaus HA; Pausz C; Freund P; Jäger U; Erker T; Vanura K
J Med Chem; 2015 Feb; 58(3):1244-53. PubMed ID: 25562417
[TBL] [Abstract][Full Text] [Related]
5. Targeting mitochondrial RNA polymerase in acute myeloid leukemia.
Bralha FN; Liyanage SU; Hurren R; Wang X; Son MH; Fung TA; Chingcuanco FB; Tung AY; Andreazza AC; Psarianos P; Schimmer AD; Salmena L; Laposa RR
Oncotarget; 2015 Nov; 6(35):37216-28. PubMed ID: 26484416
[TBL] [Abstract][Full Text] [Related]
6. A Cell-Based High-Throughput Screening for Inducers of Myeloid Differentiation.
Radomska HS; Jernigan F; Nakayama S; Jorge SE; Sun L; Tenen DG; Kobayashi SS
J Biomol Screen; 2015 Oct; 20(9):1150-9. PubMed ID: 26109609
[TBL] [Abstract][Full Text] [Related]
7. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1.
Lu F; Zhang J; Ji M; Li P; Du Y; Wang H; Zang S; Ma D; Sun X; Ji C
Int J Oncol; 2014 Jul; 45(1):383-92. PubMed ID: 24756163
[TBL] [Abstract][Full Text] [Related]
8. Cellular drug resistance in childhood acute myeloid leukemia. A mini-review with emphasis on cell culture assays.
Kaspers GJ; Zwaan CM; Pieters R; Veerman AJ
Adv Exp Med Biol; 1999; 457():415-21. PubMed ID: 10500817
[TBL] [Abstract][Full Text] [Related]
9. First Results from a Screening of 300 Naturally Occurring Compounds: 4,6-dibromo-2-(2',4'-dibromophenoxy)phenol, 4,5,6-tribromo-2-(2',4'-dibromophenoxy)phenol, and 5-epi-nakijinone Q as Substances with the Potential for Anticancer Therapy.
Mayer S; Prechtl M; Liebfried P; Cadeddu RP; Stuhldreier F; Kohl M; Wenzel F; Stork B; Wesselborg S; Proksch P; Germing U; Haas R; Jäger P
Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31491907
[TBL] [Abstract][Full Text] [Related]
10. High expression of two diverged homeobox genes, HB24 and HB9, in acute leukemias: molecular markers of hematopoietic cell immaturity.
Deguchi Y; Yamanaka Y; Theodossiou C; Najfeld V; Kehrl JH
Leukemia; 1993 Mar; 7(3):446-51. PubMed ID: 7680402
[TBL] [Abstract][Full Text] [Related]
11. Leukemia: A model for drug development.
Keating MJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2598-604. PubMed ID: 9815664
[TBL] [Abstract][Full Text] [Related]
12. LukS-PV induces mitochondrial-mediated apoptosis and G0/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells.
Bu S; Xie Q; Chang W; Huo X; Chen F; Ma X
Int J Biochem Cell Biol; 2013 Aug; 45(8):1531-7. PubMed ID: 23702031
[TBL] [Abstract][Full Text] [Related]
13. Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60).
Kachalaki S; Baradaran B; Majidi J; Yousefi M; Shanehbandi D; Mohammadinejad S; Mansoori B
Biomed Pharmacother; 2015 Oct; 75():100-4. PubMed ID: 26463638
[TBL] [Abstract][Full Text] [Related]
14. AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia.
Eriksson A; Kalushkova A; Jarvius M; Hilhorst R; Rickardson L; Kultima HG; de Wijn R; Hovestad L; Fryknäs M; Öberg F; Larsson R; Parrow V; Höglund M
Biochem Pharmacol; 2014 Jan; 87(2):284-91. PubMed ID: 24200998
[TBL] [Abstract][Full Text] [Related]
15. Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity.
Bonci D; Musumeci M; Coppola V; Addario A; Conticello C; Hahne M; Gulisano M; Grignani F; De Maria R
Haematologica; 2008 Dec; 93(12):1899-902. PubMed ID: 18838478
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of blast cell sensitivity to low-intensity laser radiation and chemotherapeutic drugs].
Karu TI; Riabykh TP; Sidorova TA; Dobrynin IaV
Dokl Akad Nauk; 1997 Mar; 353(1):114-7. PubMed ID: 9273047
[No Abstract] [Full Text] [Related]
17. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
[TBL] [Abstract][Full Text] [Related]
18. Gambogic acid induces growth inhibition and differentiation via upregulation of p21waf1/cip1 expression in acute myeloid leukemia cells.
Chen Y; Hui H; Li Z; Wang HM; You QD; Lu N
J Asian Nat Prod Res; 2014 Oct; 16(10):1000-8. PubMed ID: 24835506
[TBL] [Abstract][Full Text] [Related]
19. In vitro chemosensitivity testing in acute leukemias. Results of a retrospective study.
Lepri E; Liberati M; Menconi E; Santucci A; Piselli F; Barzi A
Anticancer Res; 1990; 10(6):1735-8. PubMed ID: 2285251
[TBL] [Abstract][Full Text] [Related]
20. Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways.
Xiong XX; Liu JM; Qiu XY; Pan F; Yu SB; Chen XQ
Acta Pharmacol Sin; 2015 Mar; 36(3):362-74. PubMed ID: 25619389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
